HOME › DRUGS › ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN
ACTIVE SUBSTANCE / INN

ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN

Brand name(s): RYLAZE
FDA LISTED
PRESCRIPTION
BLA761179
ACTIVE SUBSTANCE
Asparaginase Erwinia Chrysanthemi (Recombinant)-Rywn
REGULATORS
FDA
SPONSORS / MAH
JAZZ PHARMS
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
RYLAZEBLA761179JAZZ PHARMSPrescription

FULL INTELLIGENCE ON ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →